subject: PR:000001379

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: PR:000001379

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7

tested_intervention: unsure


subject: PR:000001379

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: PR:000001379

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: PR:000001379

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: PR:000001379

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: PR:000001379

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: PR:000001379

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PR:000001379

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: PR:000001379

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: PR:000001379

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: PR:000001379

object_name: Stage IIIC Ovarian Cancer


subject: PR:000001379

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: PR:000001379

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: PR:000001379

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: PR:000001379

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: PR:000001379

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: PR:000001379

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: PR:000001379

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: PR:000001379

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: PR:000001379

object_name: Recurrent Fallopian Tube Carcinoma


subject: PR:000001379

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PR:000001379

object_name: Stage IV Ovarian Cancer AJCC v8


subject: PR:000001379

object_name: Ovarian cancer stage IV


subject: PR:000001379

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: PR:000001379

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: PR:000001379

object_name: ovarian clear cell cancer


subject: PR:000001379

object_name: ovarian serous adenocarcinoma


subject: PR:000001379

object_name: malignant ovarian serous tumor


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:5TAA004E22

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C3886640

object_name: Adult Acute Myeloid Leukemia in Remission


subject: UMLS:C3886640

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib


subject: PUBCHEM.COMPOUND:77256380


subject: MESH:C000624167

subject_name: Utrogestan

object_name: Premature Labor


subject: UMLS:C5235210

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5235210

object_name: obesity


subject: UMLS:C5235210

object_name: Obesity, CTCAE


subject: CHEBI:6916

subject_name: Mexiletine

object_name: superficial epidermolytic ichthyosis

tested_intervention: yes


subject: CHEBI:6916

object_name: irritable bowel syndrome


subject: CHEBI:167574

subject_name: Semaglutide

object_name: spinal cord injury


subject: CHEBI:135942

subject_name: Laropiprant

object_name: Hay fever


subject: PUBCHEM.COMPOUND:4695

subject_name: Isosulfan blue

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:4695

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:4695

object_name: head and neck cancer


subject: UNII:39N9K8S2A4

subject_name: isosulfan blue


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UMLS:C4079949

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4079949

object_name: non-Hodgkin lymphoma


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: neurofibromatosis 1


subject: CHEBI:6887

object_name: neurofibromatosis type 1


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:8871

subject_name: Risperidone

object_name: Apathy


subject: CHEBI:8871

object_name: On examination - apathetic


subject: CHEBI:8871

object_name: Schizophrenic psychoses


subject: PUBCHEM.COMPOUND:9821941

subject_name: lumateperone


subject: PUBCHEM.COMPOUND:9821941


subject: PUBCHEM.COMPOUND:9821941


subject: UMLS:C1154269

subject_name: Eye drops brand of Tetrahydrozoline

object_name: dry eye syndrome


subject: CHEBI:190706

subject_name: Ile-Leu

object_name: idiopathic CD4 lymphocytopenia


subject: CHEBI:63895

subject_name: ionic liquid


subject: UMLS:C0021764

subject_name: Interleukins


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: HIV-Associated Lipodystrophy Syndrome


subject: GTOPDB:9110

object_name: triple-negative breast carcinoma


subject: GTOPDB:9110

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:9110

object_name: endometrial carcinoma


subject: GTOPDB:9110

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:9110

object_name: melanoma


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: OPTN-related open angle glaucoma


subject: UNII:T60AV22R32

subject_name: Chlorazine

object_name: Heartburn


subject: UNII:T60AV22R32

object_name: Esophageal reflux observation


subject: CHEBI:3647

subject_name: Chlorpromazine


subject: CHEBI:3647


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:3962


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: acute mountain sickness


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE


subject: CHEBI:17688

subject_name: Nicotine

object_name: Post-Operative Pain


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB

object_name: Lymphoblasts 20 Percent or More of Peripheral Blood White Cells


subject: UNII:P93RUU11P7

object_name: Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells


subject: UNII:P93RUU11P7

object_name: Blasts 5 Percent or More of Peripheral Blood White Cells


subject: UNII:P93RUU11P7

object_name: Blasts 5 Percent or More of Bone Marrow Nucleated Cells


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: CHEBI:28445

subject_name: vincristine

object_name: CD22 Positive


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C1711297

subject_name: MUC-1 Peptide Vaccine


subject: UMLS:C1711297


subject: UMLS:C1711297

object_name: Childhood Breast Carcinoma


subject: UMLS:C1711297

object_name: breast carcinoma


subject: UMLS:C1711297

object_name: breast cancer


subject: UMLS:C1711297

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: malignant neoplasm of breast stage I


subject: UMLS:C1711297

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: Carcinoma breast stage I


subject: UMLS:C1711297

object_name: Breast cancer stage II


subject: UMLS:C1711297

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C1711297

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C1711297

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C1711297

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C1711297

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C1711297

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C1711297

object_name: inflammatory breast carcinoma


subject: UMLS:C2826163

subject_name: MUC1 Peptide-Poly-ICLC Vaccine

object_name: triple-negative breast carcinoma


subject: UMLS:C2826163

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C2826163

object_name: Childhood Breast Carcinoma


subject: UMLS:C2826163

object_name: breast carcinoma


subject: UMLS:C2826163

object_name: breast cancer


subject: UMLS:C2826163

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: malignant neoplasm of breast stage I


subject: UMLS:C2826163

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: Carcinoma breast stage I


subject: UMLS:C2826163

object_name: Breast cancer stage II


subject: UMLS:C2826163

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C2826163

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C2826163

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C2826163

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C2826163

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C2826163

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2826163

object_name: inflammatory breast carcinoma


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: triple-negative breast carcinoma


subject: DRUGBANK:DB17293

object_name: Triple-Negative Breast Cancer Finding


subject: DRUGBANK:DB17293

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: malignant neoplasm of breast stage I


subject: DRUGBANK:DB17293

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Carcinoma breast stage I


subject: DRUGBANK:DB17293

object_name: Breast cancer stage II


subject: DRUGBANK:DB17293

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: DRUGBANK:DB17293

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Stage IIIB Breast Carcinoma


subject: DRUGBANK:DB17293

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Stage IIIA Breast Carcinoma


subject: DRUGBANK:DB17293

object_name: Stage IIIC Breast Cancer AJCC v6


subject: DRUGBANK:DB17293

object_name: Stage IIIC Breast Cancer AJCC v7


subject: DRUGBANK:DB17293

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: inflammatory breast carcinoma


subject: UNII:7KYP9TKT70

subject_name: poly ICLC

object_name: triple-negative breast carcinoma


subject: UNII:7KYP9TKT70

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:7KYP9TKT70

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: malignant neoplasm of breast stage I


subject: UNII:7KYP9TKT70

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: Carcinoma breast stage I


subject: UNII:7KYP9TKT70

object_name: Breast cancer stage II


subject: UNII:7KYP9TKT70

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:7KYP9TKT70

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: Stage IIIB Breast Carcinoma


subject: UNII:7KYP9TKT70

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: Stage IIIA Breast Carcinoma


subject: UNII:7KYP9TKT70

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:7KYP9TKT70

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:7KYP9TKT70

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: inflammatory breast carcinoma


subject: CHEBI:35471

subject_name: psychotropic drug

object_name: post-traumatic stress disorder


subject: CHEBI:35471

object_name: alcohol-related disorders


subject: CHEBI:35471

object_name: substance-related disorder


subject: CHEBI:35471

object_name: mild neurocognitive disorder


subject: CHEBI:35471

object_name: mild cognitive impairment


subject: CHEBI:35471

object_name: Depressed mood


subject: CHEBI:35471

object_name: Cancer patients and suicide and depression


subject: CHEBI:35471

object_name: Depressed - symptom


subject: CHEBI:35471

object_name: Depression, CTCAE


subject: CHEBI:35471

object_name: Suicidal ideation


subject: CHEBI:35471

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:35471

object_name: outcomes general quality of life


subject: CHEBI:35471

object_name: Perceived quality of life


subject: CHEBI:35471

object_name: Good quality of life


subject: UMLS:C0033978

subject_name: Psychotropic Drugs


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: UMLS:C0033978


subject: CHEBI:9014

subject_name: Salsalate

object_name: obesity


subject: CHEBI:9014

object_name: Prediabetes


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Fused vertebrae


subject: PUBCHEM.COMPOUND:2735

object_name: Disorder of lumbar spine


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C5555041

subject_name: Emfizatamab

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5555041

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C5555041

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Stomach cancer


subject: GTOPDB:13085

object_name: gastric cancer


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C1327963

object_name: macular degeneration


subject: UMLS:C1327963

object_name: age-related macular degeneration


subject: UMLS:C1327963

object_name: retinitis pigmentosa 30


subject: CHEBI:63450

subject_name: Masitinib

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:2038

subject_name: Azacitidine


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: Soft Tissue Infection


subject: CHEBI:147408

object_name: chronic obstructive pulmonary disease


subject: CHEBI:50071

subject_name: ascopyrone P


subject: UNII:7EC9WBC6KF

subject_name: IOPOFOSINE

object_name: metastatic malignant neoplasm in the brain


subject: UNII:7EC9WBC6KF

object_name: glioblastoma


subject: UNII:7EC9WBC6KF

object_name: Brain Stem Glioblastoma


subject: UNII:7EC9WBC6KF

object_name: glioma susceptibility 1


subject: UMLS:C1701188


subject: UMLS:C1701188


subject: UMLS:C1701188


subject: UMLS:C1701188


subject: UNII:BPQ010OFD7

subject_name: RALUDOTATUG DERUXTECAN

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5555533

subject_name: Anti-CDH-6 ADC DS-6000a


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Atypical pneumonia


subject: CHEBI:60648

object_name: Primary atypical pneumonia


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Cannabis use


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Marginal zone lymphoma refractory


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:O43472U9X8

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:O43472U9X8

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:O43472U9X8


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:119915

object_name: COPD, severe early onset


subject: UMLS:C5557645

subject_name: Pulocimab


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:33390

subject_name: curium atom

object_name: retinitis pigmentosa


subject: CHEBI:33390

object_name: retinitis pigmentosa 1


subject: UNII:P699N4QOWE

object_name: septic shock


subject: CHEBI:30031


subject: UNII:7K28NB895L

subject_name: Belzutifan

object_name: Clear-cell metastatic renal cell carcinoma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:6XC1PAD3KF

object_name: humoral hypercalcemia of malignancy


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: neoplastic meningitis


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: neoplasm


subject: UNII:KX89J0DFZ8

subject_name: IMSIDOLIMAB

object_name: ichthyosis


subject: UNII:KX89J0DFZ8

object_name: inherited ichthyosis


subject: UMLS:C0249056


subject: UMLS:C0249056


subject: GTOPDB:8313

subject_name: talazoparib

object_name: BRCA2 gene mutation


subject: GTOPDB:8313

object_name: BRCA1 gene mutation


subject: GTOPDB:8313

object_name: ATM Gene Mutation


subject: GTOPDB:8313

object_name: PALB2 Gene Mutation


subject: GTOPDB:8313

object_name: refractory malignant neoplasm


subject: GTOPDB:8313

object_name: Embolism, Tumor


subject: GTOPDB:8313

object_name: Recurrent Malignant Neoplasm


subject: GTOPDB:8313

object_name: Advanced cancer


subject: UMLS:C4722575

subject_name: Coenzyme Q10 Injectable Nanosuspension

object_name: glioblastoma


subject: UMLS:C4722575

object_name: Childhood Glioblastoma


subject: UMLS:C4722575

object_name: adult glioblastoma


subject: UMLS:C4722575

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C4722575

object_name: Recurrent Glioblastoma


subject: UMLS:C4722575

object_name: brain astrocytoma


subject: UMLS:C4722575

object_name: astrocytic tumor


subject: UMLS:C4722575

object_name: Adult Gliosarcoma


subject: UMLS:C4722575

object_name: gliosarcoma


subject: UMLS:C4722575

object_name: Childhood Gliosarcoma


subject: CHEBI:233453

object_name: infectious mononucleosis


subject: CHEBI:35854

subject_name: Valaciclovir


subject: UMLS:C5784973

subject_name: Hypochlorous Acid-containing Wound Spray APR-TD011

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C5784973

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C4547475

object_name: acne


subject: PUBCHEM.COMPOUND:71364

subject_name: icatibant

object_name: Heart failure NYHA class III


subject: PUBCHEM.COMPOUND:71364

object_name: Heart failure NYHA class II


subject: PUBCHEM.COMPOUND:71364

object_name: Heart failure NYHA class I


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: Hay fever


subject: PUBCHEM.COMPOUND:137319706

subject_name: Orforglipron

object_name: hypertension


subject: PUBCHEM.COMPOUND:137319706

object_name: Hypertension, CTCAE


subject: UNII:7ZW40D021M

subject_name: ORFORGLIPRON


subject: UNII:7ZW40D021M


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: carpal tunnel syndrome


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:25812

subject_name: Ozone


subject: UNII:JG8OB4UL9Y

subject_name: FILGOTINIB MALEATE

object_name: ulcerative colitis


subject: UNII:JG8OB4UL9Y

object_name: inflammatory bowel disease 1


subject: UMLS:C5419370

subject_name: Filgotinib maleate


subject: UMLS:C5419370


subject: CHEBI:72296

subject_name: Apixaban

object_name: splenectomy; status


subject: CHEBI:15365

subject_name: Aspirin

object_name: Cirrhosis


subject: CHEBI:15365

object_name: liver cirrhosis


subject: CHEBI:15365

object_name: Venous thrombosis after immobility


subject: CHEBI:15365


subject: CHEBI:15365

object_name: portal hypertension


subject: CHEBI:4653

subject_name: Dipyridamole


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight


subject: MESH:D006495


subject: MESH:D006495


subject: MESH:D006495


subject: MESH:D006495


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:44915

subject_name: Propofol

object_name: Surgical procedure finding


subject: CHEBI:134689

subject_name: Rucaparib

object_name: Childhood Solid Neoplasm


subject: CHEBI:134689

object_name: Adult Solid Neoplasm


subject: CHEBI:134689

object_name: Solid Neoplasm


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: central nervous system cancer


subject: UMLS:C3896806


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UMLS:C4086716

subject_name: PI3K-delta Inhibitor PWT143

object_name: cancer


subject: UNII:7PCM518YLR

subject_name: Efmoroctocog alfa

object_name: hemophilia A


subject: CHEBI:6801

subject_name: Metformin

object_name: Follicular lymphoma stage III


subject: CHEBI:28864

subject_name: Tobramycin

object_name: recurrent pneumonia


subject: CHEBI:28864

object_name: Lung Infection, CTCAE


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: breast neoplasm


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UNII:D87YGH4Z0Q

subject_name: Omacor

object_name: hyperlipidemia


subject: UNII:D87YGH4Z0Q

object_name: hyperlipoproteinemia


subject: UNII:D87YGH4Z0Q

object_name: Hyperlipidemia, CTCAE


subject: UNII:D87YGH4Z0Q

object_name: Serum lipids high (finding)


subject: UNII:1IJV77EI07

subject_name: Tepotinib

object_name: colorectal neoplasm


subject: UMLS:C3640221

subject_name: Linoleyl Carbonate-Paclitaxel

object_name: melanoma


subject: CHEBI:6427

subject_name: Leuprolide

object_name: premenstrual tension


subject: CHEBI:6427

object_name: polydactyly-myopia syndrome


subject: CHEBI:6427

object_name: Menstrual disorder


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: DRUGBANK:DB16550

subject_name: Bifidobacterium animalis lactis

object_name: Helicobacter pylori infection


subject: UMLS:C2700272

subject_name: White Button Mushroom Extract

object_name: Childhood Breast Carcinoma


subject: UMLS:C2700272

object_name: breast cancer


subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:133604

object_name: Dermatologic Complication


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: UMLS:C0009325


subject: UMLS:C2752138

subject_name: aloe vera homeopathic preparation


subject: UMLS:C2752138


subject: DRUGBANK:DB13906

subject_name: Aloe vera leaf


subject: DRUGBANK:DB13906


subject: UMLS:C0995182

subject_name: Aloe vera preparation


subject: UMLS:C0995182


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Locally Advanced Rectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: neuralgia


subject: CHEBI:4466

object_name: Neuralgia, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:6456

subject_name: Lidocaine

object_name: opiate dependence


subject: CHEBI:135515

subject_name: Bendamustine

object_name: chronic kidney disease


subject: CHEBI:135515

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: UNII:660M185X4D

object_name: Disorder of transplanted kidney


subject: UNII:660M185X4D

object_name: end stage renal failure


subject: UNII:660M185X4D

object_name: Chronic uremia


subject: CHEBI:17968

subject_name: butyrate

object_name: rheumatoid arthritis


subject: MESH:D002087

subject_name: Butyrates


subject: CHEBI:30772

subject_name: Butyric Acid


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: Recurrent ovarian cancer


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: Early neonatal death


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: hepatitis C


subject: CHEBI:41879

object_name: Community-Acquired Pneumonia


subject: UMLS:C4760673

subject_name: Brentuximab Vedotin for Injection

object_name: primary interstitial lung disease specific to childhood


subject: UMLS:C4760673

object_name: interstitial lung disease specific to childhood


subject: UMLS:C4760673

object_name: Hodgkin Disease


subject: UMLS:C4760673

object_name: Adult Classical Hodgkin Lymphoma


subject: UMLS:C4760673

object_name: survival time


subject: UMLS:C4760673

object_name: Metabolic Response


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4305

subject_name: dacarbazine


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:7465

subject_name: Naltrexone

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: UMLS:C3491265

object_name: asthma


subject: CHEBI:233364

subject_name: Bryostatin

object_name: colorectal cancer


subject: CHEBI:233364

object_name: colorectal carcinoma


subject: CHEBI:233364

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: ventilator-associated pneumonia


subject: UNII:1C75676F8V

subject_name: Vaborbactam

object_name: bacterial infectious disease


subject: CHEBI:167672

subject_name: Tovorafenib

object_name: BRAF Fusion Positive


subject: CHEBI:167672

object_name: RAF1 Gene Amplification


subject: CHEBI:167672

object_name: Spitz Melanoma


subject: CHEBI:167672

object_name: spindle cell melanoma


subject: CHEBI:167672

object_name: mixed epithelioid and spindle cell melanoma


subject: CHEBI:167672

object_name: bladder transitional cell carcinoma


subject: CHEBI:167672

object_name: transitional cell carcinoma


subject: CHEBI:167672

object_name: lung adenocarcinoma


subject: CHEBI:167672

object_name: familial pancreatic carcinoma


subject: CHEBI:167672

object_name: thyroid gland papillary carcinoma


subject: CHEBI:167672

object_name: bladder tumor


subject: CHEBI:167672

object_name: urinary bladder carcinoma


subject: CHEBI:167672

object_name: urinary bladder cancer


subject: CHEBI:167672

object_name: childhood bladder carcinoma


subject: UMLS:C2194045

subject_name: antiemetic combinations

object_name: hyperemesis gravidarum


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: Recurrent Rectal Cancer


subject: UNII:7CND0TX59N

object_name: stage IVA rectal cancer


subject: UNII:7CND0TX59N

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UNII:7CND0TX59N

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UNII:7CND0TX59N

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: stage IVB rectal cancer


subject: UNII:7CND0TX59N

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UNII:7CND0TX59N

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: stage IIIA rectal cancer


subject: UNII:7CND0TX59N

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UNII:7CND0TX59N

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UNII:7CND0TX59N

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: Stage IIIC Colon Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UNII:7CND0TX59N

object_name: Colon cancer recurrent


subject: UNII:7CND0TX59N

object_name: colon mucinous adenocarcinoma


subject: UNII:7CND0TX59N

object_name: colon signet ring cell adenocarcinoma


subject: UNII:7CND0TX59N

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UNII:7CND0TX59N

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: stage IVB colon cancer


subject: UNII:7CND0TX59N

object_name: Stage IVB Colon Cancer AJCC v7


subject: UNII:7CND0TX59N

object_name: Stage IVB Colon Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: stage IVA colon cancer


subject: UNII:7CND0TX59N

object_name: Stage IVA Colon Cancer AJCC v7


subject: UNII:7CND0TX59N

object_name: Stage IVA Colon Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: rectum mucinous adenocarcinoma


subject: UNII:7CND0TX59N

object_name: rectal signet ring cell adenocarcinoma


subject: UNII:7CND0TX59N

object_name: malignant large intestine neoplasm stage IIIb


subject: UNII:7CND0TX59N

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:25646

subject_name: octanoate

object_name: Recurrent Rectal Cancer


subject: CHEBI:25646

object_name: stage IVA rectal cancer


subject: CHEBI:25646

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:25646

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:25646

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:25646

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:25646

object_name: stage IVB rectal cancer


subject: CHEBI:25646

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:25646

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:25646

object_name: stage IIIA rectal cancer


subject: CHEBI:25646

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:25646

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:25646

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:25646

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:25646

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:25646

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:25646

object_name: Colon cancer recurrent


subject: CHEBI:25646

object_name: colon mucinous adenocarcinoma


subject: CHEBI:25646

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:25646

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:25646

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:25646

object_name: stage IVB colon cancer


subject: CHEBI:25646

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:25646

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:25646

object_name: stage IVA colon cancer


subject: CHEBI:25646

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:25646

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:25646

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:25646

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:25646

object_name: malignant large intestine neoplasm stage IIIb


subject: CHEBI:25646

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:25646

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:28837

subject_name: Caprylic acid

object_name: Recurrent Rectal Cancer


subject: CHEBI:28837

object_name: stage IVA rectal cancer


subject: CHEBI:28837

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:28837

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:28837

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:28837

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:28837

object_name: stage IVB rectal cancer


subject: CHEBI:28837

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:28837

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:28837

object_name: stage IIIA rectal cancer


subject: CHEBI:28837

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:28837

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:28837

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:28837

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:28837

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:28837

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:28837

object_name: Colon cancer recurrent


subject: CHEBI:28837

object_name: colon mucinous adenocarcinoma


subject: CHEBI:28837

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:28837

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:28837

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:28837

object_name: stage IVB colon cancer


subject: CHEBI:28837

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:28837

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:28837

object_name: stage IVA colon cancer


subject: CHEBI:28837

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:28837

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:28837

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:28837

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:28837

object_name: malignant large intestine neoplasm stage IIIb


subject: CHEBI:28837

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:28837

object_name: Stage IIIB Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:184196

object_name: prostate neoplasm


subject: UMLS:C4048807


subject: UMLS:C5400059

object_name: Hepatic impairment


subject: CHEBI:71956

subject_name: retaspimycin hydrochloride

object_name: Childhood Breast Carcinoma


subject: CHEBI:71956

object_name: breast carcinoma


subject: CHEBI:71956

object_name: breast cancer


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: UMLS:C1708447

subject_name: IPI 504


subject: UMLS:C1708447


subject: UMLS:C1708447


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: childhood acute lymphoblastic leukemia


subject: GTOPDB:10492

subject_name: envafolimab

object_name: ovarian cancer


subject: GTOPDB:10492

object_name: ovarian carcinoma


subject: GTOPDB:10492

object_name: malignant epithelial tumor of ovary


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:36467

subject_name: Ciguatoxins

object_name: diffuse large B-cell lymphoma


subject: CHEBI:36467

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:36467

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:204928


subject: CHEBI:204928


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C5574748


subject: UMLS:C5574748


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UMLS:C0010377


subject: UMLS:C0010377


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UniProtKB:P41416


subject: UniProtKB:P41416


subject: UMLS:C4331906

object_name: castration-resistant prostate carcinoma


subject: CHEBI:6402

subject_name: Leflunomide

object_name: RAS Family Gene Mutation


subject: CHEBI:6402

object_name: refractory malignant neoplasm


subject: CHEBI:6402

object_name: Ras (kras or nras) gene mutation


subject: CHEBI:6402

object_name: Colorectal cancer recurrent


subject: CHEBI:6402

object_name: pancreatic neoplasm


subject: CHEBI:6402

object_name: exocrine pancreatic carcinoma


subject: CHEBI:6402

object_name: malignant pancreatic neoplasm


subject: CHEBI:6402

object_name: lung cancer


subject: CHEBI:6402

object_name: lung neoplasm


subject: CHEBI:6402

object_name: lung carcinoma


subject: CHEBI:6402

object_name: melanoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:8378

subject_name: Prednisolone

object_name: pulpitis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: colonic disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:44915

subject_name: Propofol


subject: UMLS:C1454298

subject_name: HKI 272

object_name: Advanced breast cancer


subject: UMLS:C1454298

object_name: breast neoplasm


subject: CHEBI:61397

subject_name: Neratinib


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C1258613

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C1258613

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Congenital hallux valgus


subject: CHEBI:6339

object_name: Acquired hallux valgus


subject: CHEBI:6339

object_name: Hallux valgus


subject: UNII:5G1WE425BI

subject_name: Rilzabrutinib

object_name: sickle cell disease


subject: UNII:NWN58M4F5T

subject_name: RILZABRUTINIB


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:231005

object_name: rhabdomyosarcoma


subject: CHEBI:231005

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:231005

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:90881

subject_name: Camptosar

object_name: soft tissue sarcoma


subject: CHEBI:90881

object_name: Ewing sarcoma


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:6402


subject: CHEBI:91512

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: GTOPDB:12990

subject_name: sintilimab

object_name: HER2 positive


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: concussion


subject: PUBCHEM.COMPOUND:6918224

object_name: Mild Traumatic Brain Injury


subject: CHEBI:8707

subject_name: Quetiapine


subject: CHEBI:8707


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: metastatic colorectal cancer


subject: CHEBI:6931

subject_name: Midazolam

object_name: Complication of other surgical procedures


subject: UMLS:C2740325

subject_name: Xiaflex

object_name: uterine fibroid


subject: UMLS:C2740325

object_name: leiomyoma


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Exposure to cold


subject: UMLS:C3274627

subject_name: Synbiotic Supplement

object_name: chronic gingivitis


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: coronary artery disorder


subject: CHEBI:68841

object_name: coronary atherosclerosis


subject: UMLS:C3154257

subject_name: Gadavist


subject: UMLS:C3154257


subject: UMLS:C0388020

subject_name: Gadovist


subject: UMLS:C0388020


subject: UMLS:C2713023


subject: UMLS:C2713023


subject: PUBCHEM.COMPOUND:3962

object_name: Reading Disabilities


subject: PUBCHEM.COMPOUND:3962

object_name: learning disability


subject: PUBCHEM.COMPOUND:3962

object_name: dyslexia


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:40303


subject: CHEBI:40303


subject: UMLS:C1337134

subject_name: risperidone microspheres

object_name: schizophrenia


subject: UMLS:C1337134

object_name: schizoaffective disorder


subject: UMLS:C1337134

object_name: schizophrenia 18


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: endogenous depression


subject: HMDB:HMDB0013470

object_name: major depressive disorder


subject: CHEBI:52603


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: GTOPDB:5019


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: CHEBI:16412


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: PR:000001155


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Unconsciousness


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: colorectal neoplasm


subject: UMLS:C2828372


subject: UMLS:C5205034

object_name: small cell lung carcinoma


subject: UMLS:C5555533

subject_name: Anti-CDH-6 ADC DS-6000a


subject: GTOPDB:13890

subject_name: quavonlimab


subject: UNII:GG0AN49Y59

subject_name: QUAVONLIMAB


subject: UMLS:C4725918

subject_name: Quavonlimab


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Anterior Cruciate Ligament Tear


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Stage I Carcinoma of Bladder


subject: CHEBI:45863

object_name: Stage II Bladder Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: bladder transitional cell carcinoma


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:63631

subject_name: Topiramate

object_name: Cognitive changes


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: castration-resistant prostate carcinoma


subject: CHEBI:233362

object_name: Adenocarcinoma of the prostate metastatic


subject: CHEBI:233362

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C4308025

subject_name: AAA 617


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: osteoarthritis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C5785772

subject_name: Anti-CD20/CD3 Bispecific Antibody JS203

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5785772

object_name: B-cell neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:31355

subject_name: Carboplatin


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: hypertension


subject: UMLS:C1527137

object_name: Hypertension, CTCAE


subject: UMLS:C1527137

object_name: type 1 diabetes mellitus 1


subject: UMLS:C1527137

object_name: type 1 diabetes mellitus


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:131174

subject_name: Navitoclax

object_name: myeloid neoplasm


subject: CHEBI:131174

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:131174

object_name: acute myeloid leukemia


subject: CHEBI:131174

object_name: Myelodysplasia


subject: CHEBI:133021

subject_name: Venetoclax

object_name: myelofibrosis


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: hyperaldosteronism


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: sarcopenia


subject: PUBCHEM.COMPOUND:73151030

object_name: Weight loss


subject: PUBCHEM.COMPOUND:73151030

object_name: Weight Loss, CTCAE


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: GTOPDB:12990

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: GTOPDB:12990

object_name: gallbladder cancer


subject: GTOPDB:12990

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: GTOPDB:12990

object_name: Stage III Gallbladder Cancer AJCC v8


subject: GTOPDB:12990

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: GTOPDB:12990

object_name: gallbladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4725949

subject_name: Anti-LAG-3/PD-L1 Bispecific Antibody FS118

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4725949

object_name: Advanced cancer


subject: UMLS:C4725949

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4725949

object_name: Embolism, Tumor


subject: UMLS:C4725949

object_name: Neoplasm Metastasis


subject: CHEBI:72292

subject_name: Bedaquiline

object_name: drug-resistant tuberculosis


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: UNII:2XOI31YC4N

subject_name: Pretomanid


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: CHEBI:45285

object_name: multidrug-resistant tuberculosis


subject: MESH:D003802

subject_name: Dentifrices

object_name: Dental Plaque


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal

object_name: osteoarthritis


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Rectal cancer stage I


subject: CHEBI:31348

object_name: Stage I Rectal Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:152165

object_name: osteoarthritis, knee


subject: CHEBI:63918

subject_name: Artesunate

object_name: Crohn disease


subject: CHEBI:177512

subject_name: Sagopilone

object_name: prostate carcinoma


subject: CHEBI:177512

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Recurrence


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Malignant Neoplasm


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent tumor


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:45378170

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:45378170

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:45378170

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:45378170

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:45378170

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:45378170

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:45378170

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:45378170

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:45378170

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL3545248


subject: CHEMBL.COMPOUND:CHEMBL3545248


subject: CHEMBL.COMPOUND:CHEMBL3545248


subject: CHEMBL.COMPOUND:CHEMBL3545248


subject: CHEMBL.COMPOUND:CHEMBL3545248


subject: CHEMBL.COMPOUND:CHEMBL3545248


subject: CHEMBL.COMPOUND:CHEMBL3545248


subject: CHEMBL.COMPOUND:CHEMBL3545248


subject: CHEMBL.COMPOUND:CHEMBL3545248


subject: UMLS:C3273307

subject_name: PI3K/mTOR Kinase Inhibitor DS-7423


subject: UMLS:C3273307


subject: UMLS:C3273307


subject: UMLS:C3273307


subject: UMLS:C3273307


subject: UMLS:C3273307


subject: UMLS:C3273307


subject: UMLS:C3273307


subject: UMLS:C3273307


subject: CHEBI:32682

subject_name: L-argininium

object_name: hypertension, pregnancy-induced


subject: CHEBI:32682

object_name: Maternal hypertension


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: facial pain


subject: UNII:I5I8VB78VT

object_name: Facial Pain, CTCAE


subject: UNII:I5I8VB78VT

object_name: Rhinosinusitis


subject: UNII:18AP231HUP

subject_name: TEGAVIVINT

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:18AP231HUP

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:18AP231HUP

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:18AP231HUP

object_name: Stage IVA Lung Cancer AJCC v8


subject: DRUGBANK:DB17109

subject_name: Tegavivint


subject: DRUGBANK:DB17109


subject: DRUGBANK:DB17109


subject: DRUGBANK:DB17109


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Pregnant


subject: UMLS:C0125069

subject_name: L-ornithine L-aspartate

object_name: liver cirrhosis


subject: UMLS:C5854561

subject_name: Beta-catenin Antagonist ST316

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C5854561

object_name: colon carcinoma


subject: UMLS:C5854561


subject: UMLS:C5854561

object_name: colon cancer


subject: UMLS:C0593103

subject_name: Novoseven

object_name: Massive hemorrhage


subject: UMLS:C0593103

object_name: Thrombocytopenia due to massive blood transfusion


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: interstitial cystitis


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:68841

subject_name: Gadobutrol


subject: CHEBI:91407

subject_name: Momelotinib

object_name: myeloid leukemia


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest

object_name: Anorexia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: plasmacytoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450

object_name: plasma cell neoplasm


subject: CHEBI:167450

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:167450

object_name: aplastic anemia


subject: CHEBI:167450

object_name: idiopathic aplastic anemia


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:135572

subject_name: Prednylidene

object_name: rheumatoid arthritis


subject: CHEBI:149836

subject_name: Tigecycline

object_name: microbial disease


subject: UMLS:C3897616

subject_name: Shu Yu Wan Formula

object_name: lung cancer


subject: UMLS:C3897616

object_name: lung neoplasm


subject: UMLS:C3897616

object_name: lung carcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Early Stage Triple-Negative Breast Carcinoma


subject: CHEBI:4672

subject_name: Docetaxel


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:13396


subject: GTOPDB:13396

object_name: triple-negative breast carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: CHEBI:90936

subject_name: Alectinib

object_name: Nonsquamous nonsmall cell neoplasm of lung


subject: CHEBI:90936

object_name: ALK gene rearrangement positive


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: carpal tunnel syndrome 1


subject: CHEBI:3160

object_name: carpal tunnel syndrome


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Injection site irritation


subject: CHEBI:51799

subject_name: Imipenem

object_name: Primary bacterial peritonitis


subject: CHEBI:51799

object_name: acute spontaneous bacterial peritonitis


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:45783

subject_name: Imatinib

object_name: fibromatosis


subject: CHEBI:45783

object_name: desmoid tumor


subject: CHEBI:45783

object_name: Desmoid tumor


subject: CHEBI:31515

subject_name: Domperidone

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:3286

subject_name: Cabergoline

object_name: Female reproductive problem


subject: UNII:1B8447E7YI

subject_name: CLOMIPHENE CITRATE


subject: CHEBI:3752

subject_name: Clomifene


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Refractory Triple-Negative Breast Carcinoma


subject: CHEBI:8499

subject_name: Propranolol

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: CHEBI:8499

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:8499


subject: CHEBI:8499

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: osteoarthritis, knee


subject: UMLS:C0357168

subject_name: Intravenous nutrition

object_name: rotator cuff syndrome


subject: UMLS:C0357168

object_name: Rotator cuff tear


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3540032


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Advanced Melanoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UNII:LIA7Z4002P

subject_name: Nadroparin

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UNII:LIA7Z4002P

object_name: Delayed cerebral ischaemia


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: electrocardiography


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: recurrent adult acute myeloid leukemia


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: infiltrating bladder urothelial carcinoma


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:27407

subject_name: Kinetin

object_name: Riley-Day syndrome


subject: GTOPDB:1160

subject_name: hCG

object_name: ovarian reserve


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UNII:J64RI4D29U

subject_name: Acebilustat

object_name: Lymphedema of upper arm


subject: CHEBI:36219

subject_name: lactose

object_name: asthma


subject: CHEBI:36218

subject_name: beta-lactose


subject: UMLS:C1260222

subject_name: Saccharum lactis, Homeopathic preparation


subject: UMLS:C1696723

subject_name: lactose - non-drug agent


subject: CHEBI:174690

subject_name: Clenbuterol

object_name: glycogen storage disease II


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Stress urinary incontinence


subject: UMLS:C4726608

subject_name: STAT3 Inhibitor DSP-0337

object_name: neoplasm


subject: CHEBI:18248

subject_name: Iron

object_name: colon carcinoma


subject: CHEBI:18248

object_name: colorectal cancer


subject: CHEBI:18248

object_name: colon cancer


subject: CHEBI:18248

object_name: anemia as adverse effect of chemotherapeutics


subject: CHEBI:29034

subject_name: Ferric cation


subject: CHEBI:29034


subject: CHEBI:29034


subject: CHEBI:29034


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: PUBCHEM.COMPOUND:13889162

subject_name: Isomaltoside


subject: PUBCHEM.COMPOUND:13889162


subject: PUBCHEM.COMPOUND:13889162


subject: PUBCHEM.COMPOUND:13889162


subject: CHEBI:6801

subject_name: Metformin

object_name: OPTN-related open angle glaucoma


subject: CHEBI:6801

object_name: open-angle glaucoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Refractory Acute Leukemia


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:35175

subject_name: sulfate salt

object_name: Neuromuscular inhibition


subject: CHEBI:35175

object_name: Neuromuscular block, function


subject: UMLS:C0475337

subject_name: Sulfates, Unspecified or Sulfate Ion


subject: UMLS:C0475337


subject: CHEBI:26836

subject_name: Sulfuric acid


subject: CHEBI:26836


subject: CHEBI:16189

subject_name: Sulfate ion


subject: CHEBI:16189


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: UMLS:C3540792


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C1515637

subject_name: Human gp100 Plasmid DNA Vaccine

object_name: skin melanoma


subject: UMLS:C1709081

subject_name: Mouse gp100 Plasmid DNA Vaccine


subject: CHEBI:36796

subject_name: duloxetine

object_name: Fibromyalgia, Primary


subject: CHEBI:36796

object_name: Fibromyalgia, Secondary


subject: CHEBI:71157

subject_name: Dobesilic acid

object_name: infertility


subject: CHEBI:132153

subject_name: hyaluronate

object_name: dry eye syndrome


subject: CHEBI:16349

subject_name: Citrulline

object_name: asthma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: cervical cancer


subject: UMLS:C0013227

object_name: cervical carcinoma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: enthesitis


subject: UNII:DLG4EML025

object_name: Axial Spondyloarthritis


subject: UMLS:C0879396

object_name: Solid Neoplasm


subject: CHEBI:63633

subject_name: Triptorelin

object_name: uterine fibroid


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: high grade B-cell lymphoma


subject: UNII:O43472U9X8

object_name: primary mediastinal large B-cell lymphoma


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: bipolar depression


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: PUBCHEM.COMPOUND:132201704

object_name: non-small cell lung carcinoma


subject: UNII:V16D2ZT7DT

object_name: lung cancer


subject: UNII:V16D2ZT7DT

object_name: lung neoplasm


subject: UNII:V16D2ZT7DT

object_name: lung carcinoma


subject: DRUGBANK:DB14222

subject_name: Bifidobacterium longum infantis

object_name: Fatty Liver


subject: DRUGBANK:DB14222


subject: DRUGBANK:DB14222

object_name: Liver Fibrosis


subject: DRUGBANK:DB14222

object_name: liver cirrhosis


subject: CHEBI:71204

subject_name: bepotastine

object_name: atopy


subject: CHEBI:71204

object_name: dermatitis


subject: CHEBI:71204

object_name: Dermatitis


subject: CHEBI:43871

subject_name: Fasudil

object_name: Alzheimer disease type 1


subject: CHEBI:43871

object_name: Alzheimer disease


subject: CHEBI:43871

object_name: Cognitive decline, mild


subject: UNII:8202AY8I7H

subject_name: Eptinezumab

object_name: Post-Traumatic Headache


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Progressive Disease


subject: CHEBI:4466

object_name: late-onset Parkinson disease


subject: CHEBI:4466

object_name: Paget disease of the nipple


subject: CHEBI:4466

object_name: Global Progressive Disease in Viscera


subject: CHEBI:4466

object_name: RECIL PD


subject: CHEBI:4466

object_name: Global Progressive Disease in Skin


subject: CHEBI:4466

object_name: Global Progressive Disease


subject: CHEBI:4466

object_name: Global Progressive Disease in Lymph Nodes


subject: CHEBI:4466

object_name: Global Progressive Disease in Blood


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:135697

subject_name: Sarpogrelate

object_name: diabetes mellitus


subject: CHEBI:135697

object_name: Chronic uremia


subject: UMLS:C4688343

object_name: prostate carcinoma


subject: UMLS:C4688343

object_name: prostate cancer


subject: GTOPDB:9596

subject_name: oleclumab


subject: GTOPDB:9596


subject: UNII:5CRY01URYQ

subject_name: OLECLUMAB


subject: UNII:5CRY01URYQ


subject: UMLS:C4085967

subject_name: Oleclumab


subject: UMLS:C4085967


subject: UMLS:C4721816

object_name: colorectal cancer


subject: UMLS:C4721816

object_name: colorectal carcinoma


subject: UMLS:C4721816

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1451033


subject: UMLS:C1451033


subject: UMLS:C1451033


subject: UMLS:C1879762

subject_name: Aurora Kinase Inhibitor


subject: UMLS:C1879762


subject: UMLS:C1879762


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Anterior Cruciate Ligament Tear


subject: CHEBI:94518

object_name: Anterior Cruciate Ligament Injuries


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:36088


subject: UNII:4RKP5CSA1O

subject_name: Anisodamine hydrobromide

object_name: Sepsis


subject: UNII:4RKP5CSA1O

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:2198


subject: PUBCHEM.COMPOUND:2198


subject: UMLS:C0951215

subject_name: anisodamine hydrobromide


subject: UMLS:C0951215


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: Nausea, CTCAE_5


subject: UNII:YZS3R7LP44

object_name: Nausea


subject: UNII:YZS3R7LP44

object_name: Nausea, CTCAE_3


subject: UNII:YZS3R7LP44

object_name: Vomiting, CTCAE


subject: UNII:YZS3R7LP44

object_name: Vomiting


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: marginal zone lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: MALT lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Muscle spasm


subject: CHEBI:28787

object_name: Hyperkinesia


subject: CHEBI:28787

object_name: Cardiac catheterisation as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: UMLS:C0914799

object_name: HIV infection


subject: MESH:C000720494

object_name: type 2 diabetes mellitus


subject: UMLS:C5706414

subject_name: Mutant-selective PI3K-alpha Inhibitor BPI-21668

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: malignant mesothelioma


subject: UMLS:C1948073


subject: PUBCHEM.COMPOUND:9884233

subject_name: ALBUTEROL SULFATE

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:9884233

object_name: COPD, severe early onset


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: UNII:J697UZ2A9J


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Hepatic Complication


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:9168

subject_name: Sirolimus


subject: UNII:Q8MI0X869M

object_name: malignant soft tissue neoplasm


subject: UNII:Q8MI0X869M

object_name: sarcoma


subject: CHEBI:177416

subject_name: Pexacerfont

object_name: generalized anxiety disorder


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: solar urticaria


subject: UMLS:C0910794


subject: CHEMBL.COMPOUND:CHEMBL5095370

subject_name: TULISOKIBART

object_name: interstitial lung disease


subject: CHEMBL.COMPOUND:CHEMBL5095370

object_name: diffuse cutaneous systemic sclerosis


subject: CHEMBL.COMPOUND:CHEMBL5095370

object_name: diffuse scleroderma


subject: UMLS:C5783740

subject_name: Tulisokibart


subject: UMLS:C5783740


subject: UMLS:C5783740


subject: MESH:C000722748

subject_name: mRNA-1073 COVID-19 and influenza combined vaccine


subject: MESH:C000722748

object_name: influenza


subject: MESH:D000090983

subject_name: 2019-nCoV Vaccine mRNA-1273


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Dyslipidemia


subject: CHEBI:16347

object_name: Heart Disease Risk Factors


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:144551

subject_name: Oxybutynin

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: gestational diabetes


subject: CHEBI:2668

subject_name: Amlodipine

object_name: coronary artery disorder


subject: CHEBI:2668

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: mood disorder


subject: CHEBI:81579

subject_name: Erythropoietin


subject: GTOPDB:5015

subject_name: leptin

object_name: type 1 diabetes mellitus


subject: CHEBI:81571

subject_name: Leptin


subject: UMLS:C3535635

subject_name: leptin human


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Fractured ankle


subject: CHEBI:38290

object_name: Ankle Fracture, CTCAE


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:51098

subject_name: Motesanib

object_name: thyroid tumor


subject: CHEBI:51098

object_name: thyroid gland carcinoma


subject: CHEBI:51098

object_name: thyroid cancer


subject: UMLS:C1541476

subject_name: AMG 706


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1530450

subject_name: AMG 162


subject: PR:000010511

subject_name: molybdenum cofactor sulfurase

object_name: Birthing Labor


subject: PR:000015276

subject_name: sperm mitochondrial-associated cysteine-rich protein


subject: CHEBI:9215

subject_name: Spectinomycin


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: small cell lung carcinoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: infectious disease


subject: CHEBI:24859

subject_name: iodine atom

object_name: Dietary iodine deficiency


subject: CHEBI:17606

subject_name: Iodine


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: CHEBI:17045

subject_name: Nitrous oxide


subject: PUBCHEM.COMPOUND:46874763

object_name: cystic fibrosis


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C5565566


subject: UMLS:C1134588

object_name: Crohn disease


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:6121

subject_name: Ketamine

object_name: heart valve disorder


subject: CHEBI:32599


subject: CHEBI:32599

object_name: Acute Pain


subject: CHEBI:32599

object_name: coronary artery disorder


subject: CHEBI:32599

object_name: coronary atherosclerosis


subject: UMLS:C2002402

subject_name: SRT 501

object_name: colorectal neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Adenocarcinoma of the prostate metastatic


subject: CHEBI:6801

subject_name: Metformin

object_name: hyperlipidemia


subject: CHEBI:6801

object_name: hyperlipoproteinemia


subject: CHEBI:6801

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:6801

object_name: Serum lipids high (finding)


subject: UNII:9Q765ZIF8L

object_name: herpes zoster


subject: UNII:9Q765ZIF8L

object_name: postherpetic neuralgia


subject: UMLS:C0255289

subject_name: BCG Connaught

object_name: tuberculosis


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Kidney Calculi


subject: CHEBI:45367

subject_name: Rifabutin

object_name: Helicobacter pylori infection


subject: CHEBI:45367

object_name: Antibiotic resistant infection


subject: CHEBI:45367

object_name: Antibiotic resistant strain


subject: UMLS:C5204487

subject_name: PI3K/mTOR Kinase Inhibitor WXFL10030390

object_name: Advanced cancer


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Metastatic renal carcinoma


subject: UMLS:C3896806


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:124965

subject_name: Opaganib

object_name: cholangiocarcinoma


subject: CHEBI:124965

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:124965

object_name: Extrahepatic Cholangiocarcinoma


subject: CHEBI:124965

object_name: Klatskin Tumor


subject: CHEBI:124965

object_name: Cholangiocarcinoma non-resectable


subject: UMLS:C2933332


subject: UMLS:C2933332


subject: UMLS:C2933332


subject: UMLS:C2933332


subject: UMLS:C2933332


subject: UMLS:C2933331

subject_name: Yeliva


subject: UMLS:C2933331


subject: UMLS:C2933331


subject: UMLS:C2933331


subject: UMLS:C2933331


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: carcinoma


subject: MESH:C079198

object_name: liver disorder


subject: UMLS:C0937598

subject_name: apple pectin

object_name: food allergy


subject: CHEBI:143528

subject_name: DL-Arabinose


subject: UNII:47EQO8LE7H

subject_name: citrus pectin


subject: CHEBI:31466

subject_name: Dequalinium

object_name: bacterial vaginosis


subject: CHEBI:41872


subject: GTOPDB:9340

subject_name: ontamalimab

object_name: Fatty Liver


subject: UNII:6LGI7RV4PB


subject: UMLS:C5139910


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: Chronic uremia


subject: UMLS:C0813973

subject_name: Medical Marijuana

object_name: Diabetic peripheral neuropathic pain


subject: UNII:6897GXD6OE

object_name: Heart failure with normal ejection fraction


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: hepatorenal syndrome


subject: CHEBI:135949

object_name: acute kidney failure


subject: CHEBI:135949

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:135949

object_name: Hepatic ascites


subject: CHEBI:33283

subject_name: THIAMINE

object_name: type 2 diabetes mellitus


subject: CHEBI:33283

object_name: Diabetes


subject: CHEBI:33283

object_name: diabetes mellitus


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Acute myeloid leukemia in remission


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Caesarean section


subject: CHEMBL.COMPOUND:CHEMBL2219773

subject_name: CUSTIRSEN SODIUM

object_name: castration-resistant prostate carcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: metastatic squamous cell carcinoma


subject: CHEBI:31355

object_name: laryngeal squamous cell carcinoma


subject: CHEBI:31355

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:31355

object_name: hypopharynx squamous cell carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: oropharynx squamous cell carcinoma


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: collecting duct carcinoma


subject: UNII:DPT0O3T46P

object_name: kidney medullary carcinoma


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB


subject: UNII:DLE8519RWM


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: PUBCHEM.COMPOUND:156855755

object_name: Mesothelioma


subject: PUBCHEM.COMPOUND:156855755

object_name: mesothelial neoplasm


subject: PUBCHEM.COMPOUND:156855755

object_name: malignant mesothelioma


subject: UMLS:C5667001

subject_name: YAP/TEAD Interaction Inhibitor IAG933


subject: UMLS:C5667001


subject: UMLS:C5667001


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:521372

object_name: Suicide


subject: UMLS:C2012940

subject_name: tetrahydrocannabinol (medication)


subject: UMLS:C2012940


subject: UMLS:C2012940

object_name: Cannabis use


subject: UMLS:C2012940

object_name: post-traumatic stress disorder


subject: UMLS:C2012940

object_name: cannabis abuse


subject: CHEBI:66964

subject_name: Dronabinol


subject: CHEBI:66964


subject: UMLS:C5555615

subject_name: Anti-claudin18.2 Monoclonal Antibody ASKB589


subject: UMLS:C5555615

object_name: gastric adenocarcinoma


subject: CHEBI:6030

subject_name: Isoniazid

object_name: type 2 diabetes mellitus


subject: UMLS:C4760654

subject_name: Alteplase for Injection

object_name: Acute Ischemic Stroke


subject: UMLS:C4760654

object_name: Ischemic stroke


subject: MESH:C000718746


subject: CHEBI:135926

subject_name: Udenafil

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:135926

object_name: pulmonary hypertension


subject: CHEBI:135926

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:135926

object_name: pulmonary arterial hypertension


subject: CHEBI:8871

subject_name: Risperidone

object_name: Fasting


subject: CHEBI:291342

subject_name: Desloratadine

object_name: Allergic disorder of skin


subject: CHEBI:8378

subject_name: Prednisolone


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: smoldering plasma cell myeloma


subject: CHEBI:59773

subject_name: CROMOLYN

object_name: Acute Stroke


subject: CHEBI:59773

object_name: Acute Stroke Related to COVID-19


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Burkitt lymphoma associated with AIDS


subject: CHEBI:4026

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: CHEBI:4026

object_name: Immunoblastic lymphoma associated with AIDS


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:2677

subject_name: Augmentin

object_name: vaginal laceration during delivery


subject: RXCUI:151392


subject: CHEBI:50687

subject_name: metronidazole hydrochloride


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:3745

subject_name: clindamycin


subject: UNII:35A26E427H

subject_name: Reslizumab

object_name: sinusitis


subject: UNII:35A26E427H

object_name: Sinusitis, CTCAE


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: systemic sclerosis


subject: CHEBI:85164


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: interstitial lung disease


subject: UNII:I031V2H011


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Cholangiocarcinoma non-resectable


subject: UNII:CGA81G3KR5

subject_name: PUCOTENLIMAB


subject: UMLS:C5205493

subject_name: Pucotenlimab


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: myocardial infarction


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: Myocardial Infarction, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: UMLS:C1314413


subject: UMLS:C1314413


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:59173


subject: CHEBI:59173


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: opiate dependence


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Angiomyolipoma


subject: CHEBI:58097

object_name: supratentorial cancer


subject: CHEBI:17303

subject_name: Morphine


subject: UNII:52EG7RFE6Y

object_name: rheumatoid arthritis


subject: CHEBI:9123

subject_name: Sertraline

object_name: social phobia


subject: UMLS:C0056562

subject_name: crystalloid solutions

object_name: adverse effect


subject: UMLS:C0056562

object_name: Adverse effects


subject: UMLS:C0056562

object_name: Adverse reactions


subject: DRUGBANK:DB09106

subject_name: hetastarch


subject: DRUGBANK:DB09106


subject: DRUGBANK:DB09106


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Blast Phase


subject: CHEBI:79699

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:79699

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:79699

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:79699

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:79699

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:79699

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:79699

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:79699

object_name: chronic myelomonocytic leukemia


subject: CHEBI:79699

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:79699

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:79699

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:79699

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:79699

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:79699

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:79699

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:91398

subject_name: Tivantinib

object_name: metastatic colorectal cancer


subject: UMLS:C0456388

subject_name: Blood product

object_name: Irritable heart


subject: UMLS:C0456388

object_name: fibromyalgia


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination

object_name: Enterobacteriaceae Infections


subject: UMLS:C2715580

object_name: hepatitis C


subject: CHEBI:36467

subject_name: Ciguatoxins

object_name: metastatic prostate carcinoma


subject: CHEBI:204928

subject_name: Cefotaxime


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: heart failure


subject: PUBCHEM.COMPOUND:71226663

object_name: Heart Failure, CTCAE


subject: UMLS:C1095795

subject_name: EGb 761

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Moderate dementia


subject: UMLS:C0042210

object_name: mild neurocognitive disorder


subject: UMLS:C0042210

object_name: mild cognitive impairment


subject: UMLS:C0042210

object_name: Alzheimer disease type 1


subject: UMLS:C0042210

object_name: Alzheimer disease


subject: UMLS:C0042210

object_name: Mild dementia


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: CHEBI:41001

subject_name: Benzoylecgonine


subject: CHEBI:41001


subject: CHEBI:41001


subject: CHEBI:41001


subject: CHEBI:41001


subject: CHEBI:41001


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: PUBCHEM.COMPOUND:251912


subject: PUBCHEM.COMPOUND:251912


subject: PUBCHEM.COMPOUND:251912


subject: PUBCHEM.COMPOUND:251912


subject: PUBCHEM.COMPOUND:251912


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C2698319


subject: UMLS:C2698319


subject: UMLS:C2698319


subject: UMLS:C2698319


subject: UMLS:C2698319


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: PR:000002994


subject: PR:000002994


subject: PR:000002994


subject: PR:000002994


subject: PR:000002994


subject: DRUGBANK:DB15433

object_name: Ebola hemorrhagic fever


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Child Malnutrition


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:8346

subject_name: Potassium Iodide

object_name: Graves disease


subject: CHEBI:8346

object_name: hyperthyroidism


subject: CHEBI:8346

object_name: Hyperthyroidism, CTCAE


subject: UMLS:C5203926

subject_name: EZH2 Inhibitor SHR2554

object_name: cancer


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: vitamin D deficiency


subject: CHEBI:2567

subject_name: Alendronic acid


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:64153

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:64153

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:64153

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:64153

object_name: Prostate cancer recurrent


subject: CHEBI:64153

object_name: prostate adenocarcinoma


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: UMLS:C0879272

object_name: prostate carcinoma


subject: UMLS:C0879272

object_name: prostate cancer


subject: CHEBI:42588

subject_name: Fenretinide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:42588

object_name: obesity


subject: CHEBI:42588

object_name: Obesity, CTCAE


subject: CHEBI:42588

object_name: type 2 diabetes mellitus


subject: CHEBI:42588

object_name: Insulin resistance


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: Prematurity of fetus


subject: UNII:37KZM6S21G

object_name: Premature infant


subject: UNII:37KZM6S21G

object_name: cerebral palsy


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UMLS:C5873954

subject_name: SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains)


subject: UMLS:C5873955

subject_name: Bimervax


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: childhood neoplasm


subject: CHEBI:68579

object_name: neoplastic syndrome


subject: CHEBI:68579

object_name: cancer or benign tumor


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: physiological sexual disorder


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:82339

subject_name: Merphalan

object_name: Drug toxicity


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: chronic hepatitis C virus infection


subject: CHEBI:101854

subject_name: talarozole

object_name: Dermatitis


subject: CHEBI:102167

subject_name: Talarozole


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:52717

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:52717

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:44219292

subject_name: Ralinepag

object_name: hypertension


subject: PUBCHEM.COMPOUND:44219292

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:44219292

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:44219292

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:44219292

object_name: heritable pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:44219292

object_name: pulmonary hypertension, primary, 1


subject: PUBCHEM.COMPOUND:44219292

object_name: idiopathic pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:44219292

object_name: pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:44219292

object_name: pulmonary artery hypoplasia


subject: PUBCHEM.COMPOUND:44219292

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:44219292

object_name: Rheumatism


subject: PUBCHEM.COMPOUND:44219292

object_name: connective tissue disorder


subject: PUBCHEM.COMPOUND:44219292

object_name: respiratory system disorder


subject: PUBCHEM.COMPOUND:44219292

object_name: aneurysm


subject: PUBCHEM.COMPOUND:44219292

object_name: lung disorder


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: UNII:CQY12ZJN6E


subject: CHEBI:91327

subject_name: Tivozanib

object_name: Hepatic impairment


subject: CHEBI:6709

subject_name: Meclizine

object_name: peripheral vertigo


subject: CHEBI:2668

subject_name: Amlodipine

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:2668

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:2668

object_name: morbid obesity


subject: UMLS:C2348498

object_name: acute myeloid leukemia


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:1C6V77QF41

object_name: COPD, severe early onset


subject: UMLS:C4547378

object_name: Pseudomonas aeruginosa infection


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Proliferative Glomerulonephritis with Monoclonal IgG Deposits


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: primary biliary cholangitis


subject: CHEBI:173106

subject_name: ferroptocide


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: CHEBI:82960

subject_name: Raltegravir


subject: UNII:4Z63YK6E0E

object_name: Paraproteinemia


subject: UNII:4Z63YK6E0E

object_name: monoclonal gammopathy of uncertain significance


subject: UMLS:C2699451

subject_name: Coriolus Versicolor Extract

object_name: Estrogen Receptor-Positive Breast Carcinoma


subject: UMLS:C2699451

object_name: Her2-receptor negative breast cancer


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: viral disease


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: plantar fasciitis


subject: UMLS:C3537001

subject_name: ALT 711

object_name: hypertension


subject: UMLS:C3537001

object_name: Hypertension, CTCAE


subject: UMLS:C3537001

object_name: Left ventricular hypertrophy


subject: CHEMBL.COMPOUND:CHEMBL4802185

subject_name: MAPLIRPACEPT

object_name: plasma cell myeloma


subject: UMLS:C4725956

subject_name: SIRPa-IgG4 Fc


subject: UMLS:C3827197

subject_name: CFI 400945 Fumarate

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3827197

object_name: acute myeloid leukemia


subject: UMLS:C3827197

object_name: Myelodysplasia


subject: UMLS:C3827197

object_name: refractory malignant neoplasm


subject: UMLS:C3827197

object_name: Recurrent Carcinoma


subject: UMLS:C4552025

subject_name: Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine

object_name: nephroblastoma


subject: UMLS:C4552025

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C4552025

object_name: rhabdomyosarcoma


subject: UMLS:C4552025

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C4552025

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C4552025

object_name: adult lymphoma


subject: UMLS:C4552025

object_name: lymphoma


subject: UMLS:C4552025

object_name: pediatric lymphoma


subject: UMLS:C4552025

object_name: Childhood Neuroblastoma


subject: UMLS:C4552025

object_name: neuroblastoma


subject: UMLS:C4552025

object_name: Ewing sarcoma


subject: UMLS:C3640996

subject_name: Uniformly-labeled [13C]glucose

object_name: Ascites


subject: UMLS:C3640996

object_name: Ascites, CTCAE


subject: UMLS:C3640996

object_name: ovarian cancer


subject: UMLS:C3640996

object_name: ovarian neoplasm


subject: UMLS:C3640996

object_name: ovarian carcinoma


subject: CHEBI:9757

subject_name: Tropicamide

object_name: Fabry disease


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: small cell carcinoma


subject: UMLS:C3641122


subject: GTOPDB:8323

subject_name: monalizumab

object_name: Small cell lung cancer extensive stage


subject: GTOPDB:8323

object_name: small cell lung carcinoma


subject: GTOPDB:8323


subject: UNII:3ZXZ2V0588


subject: UNII:3ZXZ2V0588


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: UMLS:C3896730


subject: UMLS:C3896730


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin

object_name: Hodgkin Disease


subject: UNII:KG6VO684Z6

object_name: Adult Hodgkin Lymphoma


subject: UNII:KG6VO684Z6

object_name: Childhood Hodgkin Lymphoma


subject: UNII:KG6VO684Z6

object_name: Transformed Non-Hodgkin Lymphoma


subject: UNII:KG6VO684Z6

object_name: mantle cell lymphoma


subject: UNII:KG6VO684Z6

object_name: Burkitt lymphoma


subject: UNII:KG6VO684Z6

object_name: Childhood Burkitt Lymphoma


subject: UNII:KG6VO684Z6

object_name: Adult Burkitt Lymphoma


subject: UNII:KG6VO684Z6

object_name: follicular lymphoma


subject: UNII:KG6VO684Z6

object_name: marginal zone lymphoma


subject: UNII:KG6VO684Z6

object_name: MALT lymphoma


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: pulmonary hypertension


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: erythromelalgia


subject: CHEBI:7726

subject_name: octreotide

object_name: diabetic macular edema


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:42797

subject_name: Gabapentin

object_name: acute kidney failure


subject: CHEBI:42797

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C2606108

subject_name: ASA 404

object_name: urothelial carcinoma


subject: UMLS:C2606108

object_name: transitional cell carcinoma


subject: CHEBI:9150

subject_name: Simvastatin

object_name: diabetes mellitus


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:93786